In vitro activity of the novel antifungal compound F901318 against difficult-to-treat Aspergillus isolates

Abstract

F901318 showed potent and consistent in vitro activity against difficult-to-treat Aspergillus spp. with intrinsic and acquired antifungal resistance due to known and unknown resistance mechanisms, suggesting no significant implications of azole resistance mechanisms for the mode of action of F901318.